Bioventus Inc. (BVS): Total Assets

Annual figures by period end, from SEC filings.

$683.56M
As of 2025-12-31
$673.35M
As of 2026-06-27
-20.7%
3-year compound annual growth
+6.7%
5-year compound annual growth
$1.37B2020-12-31: $494.47M2021-12-31: $1.23B2022-12-31: $1.37B2023-12-31: $810.91M2024-12-31: $727.96M2025-12-31: $683.56M$683.56M
2020-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$683.56M-6.1%2026-03-05, Balance as of period end
2024-12-31$727.96M-10.2%2026-03-05, Balance as of period end
2023-12-31$810.91M-40.9%2025-03-11, Balance as of period end
2022-12-31$1.37B+12.0%2024-03-12, Balance as of period end
2021-12-31$1.23B+147.9%2023-03-31, Balance as of period end
2020-12-31$494.47Mn/a2022-03-11, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Bioventus Inc. (BVS)2025-12-31$683.56M-6.1%
UFP Technologies Inc (UFPT)2025-12-31$655.08M+4.1%
AtriCure, Inc. (ATRC)2025-12-31$654.18M+7.4%
Glaukos Corp (GKOS)2025-12-31$893.49M-8.3%
NovoCure Ltd (NVCR)2025-12-31$804.33M-35.2%
Artivion, Inc. (AORT)2025-12-31$884.80M+12.1%
iRhythm Holdings, Inc. (IRTC)2025-12-31$1.02B+9.5%
Alphatec Holdings, Inc. (ATEC)2025-12-31$791.21M+2.0%
Mimedx Group, Inc. (MDXG)2025-12-31$342.65M+29.8%

Compare BVS, UFPT, ATRC, GKOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗